Diabetes decisions — 2025

The Board denied service connection for diabetes mellitus, type II and remanded the claims for hypertension and PTSD.

The Board denied the Veteran's claim for a compensable rating for diabetes mellitus, type II.

The Board denied service connection for diabetes, neuropathy of the bilateral lower and upper extremities, and sleep apnea as not being related to the Veteran's military service. The Board also denied an increased rating for depression prior to August 1, 2022, and earlier effective dates for TDIU and DEA.

The Board granted service connection for diabetes mellitus type II based on the Veteran's exposure to herbicide agents during his service aboard the USS Enterprise.

The Board granted increased disability ratings of 40 percent for right and left lower extremity peripheral neuropathy, but denied higher ratings for diabetes mellitus type II and PTSD.

The Veteran withdrew the appeal for service connection of diabetes mellitus type II.

The Board granted the veteran's claim for a certificate of eligibility (COE) for VA home loan guaranty benefits based on his service-connected diabetes mellitus.

The Board granted service connection for diabetes mellitus and dismissed the appeals for service connection of various other conditions as well as for compensable ratings.

The Board remands the veteran's claims for service connection for various conditions, including rheumatoid arthritis, right hip degenerative joint disease, osteoarthritis, psoriatic arthritis, hypertension, enlarged liver, prostate cancer, diabetes mellitus type II, fever sores, and a compromised immune system, to ensure compliance with prior remand instructions.

The Board remands the claims for service connection for hypertension, prostate disorder, and diabetes mellitus due to further development needed.

The Board remands the claims for service connection for obstructive sleep apnea, sclerosing mesenteritis, and diabetes mellitus type 2 to obtain additional evidence regarding the Veteran's exposure to toxic substances during his service.

The Board granted the restoration of service connection for diabetes mellitus, type II and diabetic neuropathy in all four lower extremities, as severance was found to be improper.

The Board granted an effective date of January 21, 2020 for the award of service connection for diabetes mellitus, type II, prostate cancer, erectile dysfunction, and special monthly compensation (SMC) based on loss of use of a creative organ.

The Board remands the claim for service connection for diabetes mellitus type II to obtain a more thorough medical opinion.

The Board granted service connection for multiple osteoarthritis conditions, headaches, an acquired psychiatric disorder, diabetes mellitus, sleep apnea, and gout based on the evidence showing a relationship to the Veteran's active duty service.

The Board remands the claims for service connection to correct duty to assist errors and obtain adequate medical opinions.

The Board granted service connection for tinnitus and dismissed the appeal for PTSD, as well as other claims for service connection that were not supported by evidence.

The Board denied service connection for bilateral hearing loss and remanded claims for an acquired psychiatric condition, insomnia, diabetes mellitus, and migraine headaches.

The Board granted earlier effective dates for service connection and ratings for various conditions, including diabetes mellitus, neuropathy of the lower extremities, and right wrist limited dorsiflexion.

The Board denied service connection for hypertension, diabetes mellitus, type II (diabetes), and allergic rhinitis, as well as an initial compensable disability rating for sarcoidosis.